Lv3
320 积分 2022-08-01 加入
Reverse resistance to immune checkpoint inhibitor in a patient with recurrent cardia cancer by intratumoral injection of recombinant human adenovirus type 5: a case report and literature review
14小时前
已完结
Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study
14小时前
已完结
Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells
14小时前
已完结
Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers
4个月前
已完结
Response Rates to Anti-PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase
4个月前
已完结
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer
4个月前
已完结
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies
4个月前
已关闭
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
4个月前
已完结
Biomarkers for response to immunotherapy in hepatobiliary malignancies
4个月前
已完结
Biostatistics Primer What a Clinician Ought to Know: Hazard Ratios
4个月前
已完结
皖公网安备34019202002308
